Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.500
+0.040 (2.74%)
At close: Aug 3, 2026, 4:00 PM EDT
1.471
-0.029 (-1.91%)
After-hours: Aug 3, 2026, 4:41 PM EDT

Caribou Biosciences Revenue

Caribou Biosciences had revenue of $2.40M in the quarter ending March 31, 2026, with 1.87% growth. This brings the company's revenue in the last twelve months to $11.20M, up 12.96% year-over-year. In the year 2025, Caribou Biosciences had annual revenue of $11.16M with 11.66% growth.

Revenue (ttm)
$11.20M
Revenue Growth
+12.96%
P/S Ratio
12.75
Revenue / Employee
$115,495
Employees
97
Market Cap
148.77M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202511.16M1.17M11.66%
Dec 31, 20249.99M-24.48M-71.01%
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 202012.36M6.57M113.56%
Dec 31, 20195.79M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Equillium4.39M
Cibus4.29M
Korro Bio3.84M
Milestone Pharmaceuticals1.78M
Kazia Therapeutics1.27M
Entera Bio42.00K
Revenue Rankings